SSY Group (HKG:2005) obtained approval from China's National Medical Products Administration for the addition of a 0.5g specification to its Paracetamol tablets, a Friday bourse filing said.

The Chinese regulator has also approved both the 0.3g and 0.5g variants of the Paracetamol tablets as passing the consistency evaluation of the quality and efficacy of generic drugs.

The Paracetamol tablet is mainly used for fever caused by common cold or influenza, as well as for the relief of mild to moderate pain.